DNTH vs SO · rev $6.2M vs P/E 22, rev $29.55B
Dianthus Therapeutics Inc. (DNTH) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
DNTH currently screens at market cap $4.40B. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the DNTH and SO stock pages for the full models.
Not investment advice.